Post-stroke complications: Epidemiology and prospects for pharmacological intervention during rehabilitation

CNS Drugs

Volumn 9, Issue 5, 1998, Pages 357-370

  Meschia, James F ^a   Bruno, Askiel ^b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CITALOPRAM; DANTROLENE; DEXAMPHETAMINE; FLAVOXATE; FLUOXETINE; IMIPRAMINE; MAPROTILINE; NORTRIPTYLINE; OXYBUTYNIN; PHENOBARBITAL; PRAZOSIN; TERAZOSIN; THIORIDAZINE; TIZANIDINE;

APHASIA; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG INDICATION; EMOTIONALITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPASTICITY; STROKE; URINE INCONTINENCE;

EID: 0031748809     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809050-00003     Document Type: Review

References (129)

1. Adams Jr HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1996; 27: 1711-8
2. Damasio AR. Aphasia. N Engl J Med 1992; 326: 531-9
3. Bogousslavsky J, van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1.000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92
4. Stegmayr B, Asplund K, Wester PO. Trends and incidence, case-fatality rate, and severity of stroke in northern Sweden 1985-1991. Stroke 1994; 25: 1738-45
5. Pedersen PM, Jørgensen HS, Nakayama H, et al. Aphasia in acute stroke: incidence, determinants, and recovery. Ann Neurol 1995; 38: 659-66
6. Rosenbaum DH, Siegel M, Barr WB, et al. Epileptic aphasia. Neurology 1986; 36: 822-5
7. Kirshner HS, Hughes T, Fakhoury T, et al. Aphasia secondary to partial status epilepticus of the basal temporal language area. Neurology 1995; 45: 1616-8
8. Howard D. The treatment of acquired aphasia. Philos Trans R Soc Lond B Biol Sci 1994; 346: 113-20
9. West R, Stockel S. The effect of meprobamat on recovery from aphasia. J Speech Hear Res 1965; 8: 57-62
10. Gouliaev AH, Senning A. Piracetam and other structurally related nootropics. Brain Res Brain Res Rev 1994; 19: 180-222
11. Deberdt W. Interaction between psychological and pharmacological treatment in cognitive impairment. Life Sci 1994; 55: 2057-66
12. Enderby P. The efficacy and safety of piracetam in the rehabilitation of stroke patients. Int Acad Biomed Drug Res 1994; 7: 249-55
13. Gupta SR, Mlcoch AG, Scolaro C, et al. Bromocriptine treatment of nonfluent aphasia. Neurology 1995; 45: 2170-3
14. Sabe L, Salvarezza F, Cuerva AG, et al. A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995; 45: 2272-4
15. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of post-stroke mood disorders: diagnosis and outcome at one and two years. Stroke 1987; 18: 837-43
16. Parikh RM, Robinson RG, Lipsey JR, et al. The impact of post-stroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 1990; 47: 785-9
17. Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 1977; 40: 1018-20
18. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987; 110: 1045-59
19. House A, Dennis M, Warlow C, et al. Mood disorders after stroke and their relation to lesion location: a CT scan study. Brain 1990; 113: 1113-29
20. Morris PLP, Raphael B, Robinson RG. Clinical depression is associated with impaired recovery from stroke. Med J Aust 1992; 157: 239-42
21. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1948; 1: 634-59
22. Feibel JH, Springer CJ. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil 1982; 63: 276-8
23. Lipsey JR, Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984; 1: 297-300
24. Reding MJ, Orto LA, Winter SW, et al. Antidepressant therapy after stroke: a double-blind trial. Arch Neurol 1986; 43: 763-5
25. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099-104
26. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27: 1211-4
27. Lauritzen L, Bendsen BB, Vilmar T, et al. Post-stroke depression: combination treatment with imipramine or desipramine and mianserin. Psychopharmacology 1994; 114: 119-22
28. Cunningham LA. Depression in the medically ill: choosing an antidepressant. J Clin Psychiatry 1944; 55 (9 Suppl. A): 90-7
29. Lieberman A, Benson F. Control of emotional expression in pseudobulbar palsy. Arch Neurol 1977; 34: 717-9
30. Allman P, Hope RA, Fairburn CG. Emotionalism following brain damage: a complex phenomenon. Postgrad Med J 1990; 66: 818-21
31. van Gijn J. Treating uncontrolled crying after stroke. Lancet 1993; 342: 816-7
32. Andersen G, Ingeman-Nielsen M, Vestergaard K, et al. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994; 25: 1050-2
33. House A, Dennis M, Molyneax A, et al. Emotionalism after stroke. BMJ 1989; 298: 991-4
34. Lawson IR, MacLeod RD. The use of imipramine ('tofranil') and other psychotropic drugs in organic emotionalism. Br J Psychiatry 1969; 115: 281-5
35. Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993; 150: 286-93
36. Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet 1993; 342: 837-9
37. Seliger GM, Hornstein A, Flax J, et al. Fluoxetine improves emotional incontinence. Brain Inj 1992; 6: 267-70
38. Panzer MJ, Mellow AM. Antidepressant treatment of pathologic laughing or crying in elderly stroke patients. J Geriatr Psychiatry Neurol 1992; 4: 195-9
39. Hanger HC. Emotionalism after stroke. Lancet 1993; 342: 1235-6
40. Dejerine J, Roussy G. Le syndrome thalamique. Rev Neurol 1906; 14: 521-32
41. Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 1996; 61: 62-9
42. van Ouwenaller C, Laplace PM, Chantraine A. Painful shoulder in hemiplegia. Arch Phys Med Rehabil 1986; 67: 23-6
43. Schott GD. From thalamic syndrome to central poststroke pain. J Neurol Neurosurg Psychiatry 1995; 61: 560-4
44. Andersen G, Vestergaard K, Ingeman-Nielsen M, et al. Incidence of central post-stroke pain. Pain 1995; 61: 187-93
45. Vestergaard K, Nielsen J, Andersen G, et al. Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain 1995; 61: 177-86
46. Leijon CJ, Boivie J, Johansson I. Central post-stroke pain: neurological symptoms and pain characteristics. Pain 1989; 36: 13-25
47. Huntzinger JA, Deutsch SI, Rosse RB. Thalamic pain syndrome complicating the evaluation of a patient with post-stroke depression. Psychosomatics 1992; 33: 335-7
48. Kluger NJ, Clifford JS, Cavanagh RJ, et al. A case of a chemically dependent patient with a thalamic pain syndrome treated with amitriptyline. J Addict Dis 1991; 10: 97-102
49. Leijon G, Boivie J. Central post-stroke pain a controlled trial of amitriptyline and carbamazepine. Pain 1989; 36: 27-36
50. Bainton T, Fox M, Bowsher D, et al. A double-blind trial of naloxone in central post-stroke pain. Pain 1992; 48: 159-62
51. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-33
52. Awerbuch GI, Sandyk R. Mexiletine for thalamic pain syndrome. Int J Neurosci 1990; 55: 129-33
53. Taira T, Tanikawa T, Kawamura H, et al. Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry 1994; 57: 381-2
54. Gonzales GR. Central pain: diagnosis and treatment strategies. Neurology 1995; 45 Suppl. 9: 511-6
55. Bowsher D. The management of central post-stroke pain. Postgrad Med J 1995; 71: 598-604
56. Duncan PW, Goldstein LB, Matchar D, et al. Measurement of motor recovery after stroke: outcome assessment and sample size requirements. Stroke 1992; 23: 1084-9
57. Heller A, Wade DT, Wood VA, et al. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry 1987; 50: 714-9
58. Partridge CJ, Johnson M, Edwards S. Recovery from physical disability after stroke: normal patterns as a basis for evaluation. Lancet 1987; 1: 373-5
59. Parker VM, Wade DT, Hewer RL. Loss of arm function after stroke: measurement, frequency and recovery. Int Rehabil Med 1986; 8: 69-73
60. Wade DT, Wood VA, Hewer RL. Recovery after stroke - the first 3 months. J Neurol Neurosurg Psychiatry 1985; 48: 7-13
61. Wade DT, Langton-Hewer R, Wood VA, et al. The hemiplegic arm after stroke: measurement and recovery. J Neurol Neurosurg Psychiatry 1983; 46: 521-4
62. Skilbeck CE, Wade DT, Hewer RL, et al. Recovery after stroke. J Neurol Neurosurg Psychiatry 1983; 46: 5-8
63. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988; 19: 1497-500
64. Duncan PW, Goldstein LB, Horner RD, et al. Similar motor recovers of upper and lower extremities after stroke. Stroke 1994; 25: 1181-8
65. Lee RG, van Donkelaar P. Mechanisms underlying functional recovery following stroke. Can J Neurol Sci 1995; 22: 257-63
66. Boyeson MG, Feeney DM. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 1990; 35: 497-501
67. Boyeson MG, Krobert KA. Cerebellar norepinephrine infusions facilitate recovery after sensorimotor cortex injury. Brain Res Bull 1992; 29: 435-9
68. Boyeson MG, Harmon RL. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am J Phys Med Rehabil 1993; 72: 286-93
69. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855-7
70. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984; 298: 358-61
71. Crisostomo EA, Duncan DW, Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94-7
72. Fugl-Meyer AR, Jaasho L, Leyman I, et al. The post-stroke hemiplegic patient. Scand J Rehabil Med 1975; 7: 13-31
73. Walker-Batson D, Smith P, Curtis S, et al. Amphetamines paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke 1995; 26: 2254-9
74. Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Res 1990; 508: 305-9
75. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986; 376: 71-7
76. Taira T, Tanikawa T, Kawamura H, et al. Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry 1994; 57: 381-2
77. Gonzales GR. Central pain: diagnosis and treatment strategies. Neurology 1995; 45 Suppl. 9: 511-6
78. Bowsher D. The management of central post-stroke pain. Postgrad Med J 1995; 71: 598-604
79. Duncan PW, Goldstein LB, Matchar D, et al. Measurement of motor recovery after stroke: outcome assessment and sample size requirements. Stroke 1992; 23: 1084-9
80. Heller A, Wade DT, Wood VA, et al. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry 1987; 50: 714-9
81. Partridge CJ, Johnson M, Edwards S. Recovery from physical disability after stroke: normal patterns as a basis for evaluation. Lancet 1987; 1: 373-5
82. Parker VM, Wade DT, Hewer RL. Loss of arm function after stroke: measurement, frequency and recovery. Int Rehabil Med 1986; 8: 69-73
83. Wade DT, Wood VA, Hewer RL. Recovery after stroke - the first 3 months. J Neurol Neurosurg Psychiatry 1985; 48: 7-13
84. Wade DT, Langton-Hewer R, Wood VA, et al. The hemiplegic arm after stroke: measurement and recovery. J Neurol Neurosurg Psychiatry 1983; 46: 521-4
85. Skilbeck CE, Wade DT, Hewer RL, et al. Recovery after stroke. J Neurol Neurosurg Psychiatry 1983; 46: 5-8
86. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988; 19: 1497-500
87. Duncan PW, Goldstein LB, Horner RD, et al. Similar motor recovers of upper and lower extremities after stroke. Stroke 1994; 25: 1181-8
88. Lee RG, van Donkelaar P. Mechanisms underlying functional recovery following stroke. Can J Neurol Sci 1995; 22: 257-63
89. Boyeson MG, Feeney DM. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 1990; 35: 497-501
90. Boyeson MG, Krobert KA. Cerebellar norepinephrine infusions facilitate recovery after sensorimotor cortex injury. Brain Res Bull 1992; 29: 435-9
91. Boyeson MG, Harmon RL. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am J Phys Med Rehabil 1993; 72: 286-93
92. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855-7
93. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984; 298: 358-61
94. Crisostomo EA, Duncan DW, Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94-7
95. Fugl-Meyer AR, Jaasho L, Leyman I, et al. The post-stroke hemiplegic patient. Scand J Rehabil Med 1975; 7: 13-31
96. Walker-Batson D, Smith P, Curtis S, et al. Amphetamines paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke 1995; 26: 2254-9
97. Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Res 1990; 508: 305-9
98. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986; 376: 71-7
99. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 1986; 379: 104-11
100. Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res 1994; 635: 300-6
101. Goldstein LB. Common drugs may influence motor recovery after stroke. Neurology 1995; 45: 865-71
102. Brown P. Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 1994; 57: 773-7
103. Katz RT. Management of spasticity. Am J Phys Med Rchabil 1988; 67: 108-16
104. Landau WM. Spasticity: the fable of a neurological demon and the Emperor's new therapy. Arch Neurol 1974; 31: 217-9
105. Landau WM. Parables of palsy pills and PT pedagogy: a spastic dialectic. Neurology 1988; 38: 1496-9
106. O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996; 119: 1737-49
107. Medici M, Pebet M, Ciblis D. A double-blind, long-term study of tizanidine ('Sirdalud) in spasticity due to cerebrovascular lesions. Curr Med Res Opin 1989; 11: 398-407
108. Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 686-94
109. Pedersen E. A rating system for neurological impairment in multiple sclerosis. Acta Neurol Scand 1965; 41 Suppl. B: 557-8
110. Katrak PH, Cole AMD, Poulos CJ, et al. Objective assessment of spasticity , strength, and function with early exhibition of dantrolene sodium afler cerebrovascular accident: a randomized double-blind study. Arch Phys Med Rehabil 1992; 73: 4-9
111. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J 1965; 14: 61-5
112. Ketel WB, Kolb. Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function. Curr Med Res Opin 1984; 9: 161-9
113. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurology 1990; 40: 1332-6
114. Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994; 57: 1321-4
115. Hesse S, Krajnik J, Luecke D, et al. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996; 27: 455-60
116. Dengler R, Neyer U, Wohlfarth K, et al. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992; 239: 375-8
117. Burbaud P, Wiart L, Dubos JL, et al. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996; 61: 265-9
118. Snow BJ, Tsui JKC, Bhatt MH, et al. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990; 28: 512-5
119. Simpson DM, Alexander DN, OBrien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-10
120. Hulme A, MacLennan WJ, Ritchie RT, et al. Baclofen in the elderly stroke patient: its side effects and pharmacokinetics. Eur J Clin Pharmacol 1985; 29: 467-9
121. Civardi C, Naldi P, Cantello R, et al. Protirelin tartrate (TRH-T) in upper moloneuron syndrome: a controlled neurophysiological and clinical study. Ital J Neurol Sci 1994; 15: 395-406
122. Reding MJ, Winter SW, Hochrein SA, et al. Urinary incontinence after unilateral hemispheric stroke: a neurologic-epidemiologic perspective. J Neurol Rehabil 1987; 1: 25-30
123. Borrie MJ, Campbell AJ, Caradoc-Davies TH, et al. Urinary incontinence after stroke: a prospective study. Age Ageing 1986; 15: 177-81
124. Brocklehurst JC, Andrews K, Richards B, et al. Incidence and correlates of incontinence in stroke patients. J Am Geriatr Soc 1985; 33: 540-2
125. Wade DT, Hewer RL. Outlook after an acute stroke: urinary incontinence and loss of consciousness compared in 532 patients. Q J Med 1985; 56: 601-8
126. Gelber DA, Good DC, Laven LJ, et al. Causes of urinary incontinence after acute hemispheric stroke. Stroke 1993; 24: 378-82
127. Burney TL, Senapati M, Desai S, et al. Effects of cerebrovascular accident on micturition. Urol Clin North Am 1996; 23: 483-90
128. Ween JE, Alexander MP, DEsposito M, et al. Incontinence after stroke in a rehabilitation setting: outcome associations and predictive factors. Neurology 1996; 47: 659-63
129. Cook DJ, Guyatt GH, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992 Suppl. 4; 102: 305-11S